Close Menu

The Economist has a story following a PLoS Medicine paper from John Ioannidis and colleagues which argues that scientific publishing may be biased toward high-profile papers that may have less accurate findings. "With so many scientific papers chasing so few pages in the most prestigious journals, the winners could be the ones most likely to oversell themselves," the article says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.